KWMG
DFTX

King Wealth Management Group’s Definium Therapeutics DFTX Stock Holding History

King Wealth Management Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Hold
10,000
– – 0.02% 151
2025
Q4 		$134K Hold
10,000
– – 0.02% 160
2025
Q3 		$118K Hold
10,000
– – 0.01% 157
2025
Q2 		$65K Hold
10,000
– – 0.01% 156
2025
Q1 		$59K Hold
10,000
– – 0.01% 157
2024
Q4 		$70K Buy
+10,000
New +$68.8K 0.01% 152

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

King Wealth Management Group's DFTX Position: Q1 2026 in Review

King Wealth Management Group held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 10,000 shares worth $189K. The position accounts for 0.02% of the portfolio, ranked #151.

King Wealth Management Group first reported a position in DFTX in Q4 2024 and has held it in 6 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • King Wealth Management Group held 10,000 shares of Definium Therapeutics worth $189K as of Q1 2026.
  • King Wealth Management Group left its Definium Therapeutics share count unchanged in Q1 2026.
  • Definium Therapeutics made up 0.02% of King Wealth Management Group's portfolio in Q1 2026, its #151 holding.
  • King Wealth Management Group first reported a position in Definium Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on King Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.